跳至主要内容
临床试验/NCT05679648
NCT05679648尚未招募不适用

Evaluation of Hepatic Steatosis and Fibrosis in Rheumatoid Arthritis Patients: a Cross-sectional Case-control Study

Sohag University0 个研究点目标入组 100 人开始时间: 2023年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
主要终点
degree of hepatic fibrosis

研究概览

简要总结

studying the prevalence of hepatic steatosis and fibrosis in a large scale of patients with RA and healthy controls

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • RA according to the American College of Rheumatology (ACR)/EULAR 2010 criteria (Aletaha et al., 2010)
  • Age≥18 years

排除标准

  • History of hepatitis B and C virus infection.
  • Receiving hepatotoxic drugs other than RA-specific drugs.
  • Alcohol abuse (i30 g/day in men and ⩾20 g/day in women).
  • Diagnosis of Wilson's disease, α1-antitrypsin deficiency or hemochromatosis.
  • Autoimmune liver disease.
  • Pregnancy.

结局指标

主要结局

degree of hepatic fibrosis

时间窗: 1 day during examination

degree of hepatic fibrosis by FIB-4 and APRI tests

degree of hepatic steatosis

时间窗: 1 day during examination

degree of hepatic steatosis by ultrasonography and Hepatic Steatosis Index.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amr Hamed

Lecturer

Sohag University

相似试验